In an op-ed at Ms. Magazine, Population Council President Julia Bunting shares why convenience in contraception is no trivial matter for women, and why the Council’s newly-FDA-approved contraceptive may be a game-changer for some.
Annovera™ (segesterone acetate and ethinyl estradiol vaginal system) is the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control. The fact that a woman can insert and remove it for herself, does not need to refill a prescription for a year, and can store it without refrigeration, means it offers women greater choice and control, as well as convenience. Annovera and other long-acting reversible contraceptives, including the IUD and the implant, are all featured in the Population Council's latest campaign at makethemethods.com.
Convenience plays a fundamental role in a woman’s reproductive choices. You can’t take a pill if you do not have the time to pick up the pill from the pharmacy. This is one of the reasons the Population Council, the nonprofit research organization I lead, first developed the IUD. Approved for use some 20 years ago, its increasing popularity in the U.S shows that convenience is of huge interest. Women gravitate to IUDs as a “carefree” option, providing three to 10 years of protection after insertion. It also makes it remarkably effective.
But the IUD also requires a trip to the doctor to insert and remove—which takes time, money and available health services. Some women aren’t sure if or when they want to try and conceive. Now, a new option on the horizon offers the convenience of a long-acting method, but the control of a short-acting method.
Read more at Ms. Magazine.